United States· US:71610-300_a8ff5402-3a49-4f04-9868-f8b2dff3aa99

Alogliptin

A medicinal product containing alogliptin benzoate, registered in United States by Aphena Pharma Solutions - Tennessee, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAlogliptinATC—REGISTER NO.US:71610-300_a8ff5402…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ALOGLIPTIN BENZOATE
Manufacturer
Aphena Pharma Solutions - Tennessee, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    7161030009
    9000 TABLET, FILM COATED in 1 BOTTLE (71610-300-09)
  • ndc11
    7161030018
    3000 TABLET, FILM COATED in 1 BOTTLE (71610-300-18)
  • ndc11
    7161030060
    90 TABLET, FILM COATED in 1 BOTTLE (71610-300-60)
  • ndc11
    71610-300-09
  • ndc11
    71610-300-18
  • ndc11
    71610-300-60

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Alogliptin benzoate in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alogliptin benzoate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/65efc4af-8d04-45f9-9e9f-ab22bec92ed1
GET /v1/drugs/65efc4af-8d04-45f9-9e9f-ab22bec92ed1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "25",
  "substance": "ALOGLIPTIN BENZOATE",
  "productndc": "71610-300",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA022271",
  "marketing_category": "NDA AUTHORIZED GENERIC"
}

See everything about alogliptin benzoate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.